Legacy Brands Become Modern Communicators

Education is the highest form of marketing. Shannon Maverick sets on out on a quest to speak with business leaders from around B2B to better understand how they are utilizing education with their customers.

 

When thinking about the most innovative companies around today, we tend to reflect on those that have made the headlines within the last ten years, have recently gone public, have links to Silicon Valley, and so on. But perhaps more extraordinary are those companies that have been around for more than a decade, maybe even ten decades or more. These are companies that have endured major global and national events like the first and second World Wars, the Great Depression, the beginning of air travel, let alone the invention of the television or even the internet. But these companies haven’t just muddled along hoping to survive. They are companies that have reinvented themselves multiple times over the years, evolving through acquisitions or other business transformations while leveraging both resilience and a willing to adapt to stay in pace with the burgeoning landscape, the latest technology and ever-changing consumer habits.

One such company is Worthen Industries. Founded in 1866 as a one-product adhesive formulation company, by remaining at the forefront of innovation, branding and marketing, today, the company offers fifteen industry-leading Business Units with worldwide operations employing over 250+ employees while boasting an impressively large portfolio of patents.

On this episode of MarketScale’s Maverick of Marketing podcast, Steve Adams, Worthen Industries’ Business Manager, sits down with host Shannon Maverick to discuss the company’s history, their market-focused, eco-conscious, customer-centric, community-oriented business approach, as well as their extensive experience and diverse capabilities spanning a wide range of Business Units—Adhesive Coated Products, Film Laminating Adhesives, Performance Coated Fabrics, Printable Fabric Solutions, Extruded Films, Staple & Nail Products, and more—in particular, the sector Adams’ oversees: the Foam Fabricating Adhesives group, which designs, manufactures and provides adhesive solutions for foam fabricating applications, i.e., the bonding of cushioning materials found in mattress and furniture manufacturing operations.

“We’re very diverse, but where I think we were very successful at our marketing approach was by becoming more market-focused and not so scattered in our approach to any particular market.” Adams additionally remarked, “We’re always looking to provide sustainable innovation. These opportunities come up either through safety issues, environmental issues, process changes within facilities, or new products that are developed in the market that create challenges that need to be addressed. So, the result of all that is we’re not just making an industry-leading product—we create solutions that ensure that our customers’ processes, their product quality, their efficiency, and very importantly, their environmental practices are optimized.”

Listen to Previous Episodes of Maverick of Marketing Right Here!

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More
cancer
Targeting T Cells Within the Cancer Immunity Cycle
April 19, 2025

As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…

Read More
cancer Immunity cycle
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
April 19, 2025

As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…

Read More
resistance
Inside Oncology Drug Development: Overcoming Resistance with Science
April 19, 2025

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

Read More